ssussu
☆    

China,
2017-08-29 13:38
(2403 d 18:11 ago)

Posting: # 17748
Views: 2,450
 

 Extended release dosage form BE design [Design Issues]

Dear all,
According to the FDA guidance for Mirabegron extended release tablets, there are 3 studies included. Why the study of 25mg strenth under fed condition dose not need?
Additionally, about a extended release drug,if the half life is very long e.g. 70hr,dose the AUC truncte to AUC0-72h?
Is there guidance for extended release drug specially from FDA?

Please kindly give me some advice. Thank you!
UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
92 visitors (0 registered, 92 guests [including 8 identified bots]).
Forum time: 06:49 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5